Smad1 as a Biomarker for Diabetic Nephropathy
Author:
Affiliation:
1. From the Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://journals.org/diabetes/diabetes/article-pdf/57/6/1459/390819/zdb00608001459.pdf
Reference18 articles.
1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342:381–389,2000
2. Colwell JA: Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes 45 (Suppl 3):S87–S90,1996
3. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161–1165,1989
4. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH: Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?Kidney Int 67:1684–1691,2005
5. Susztak K, Bottinger EP: Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol 17:361–367,2006
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca2+ entry in glomerular mesangial cells;American Journal of Physiology-Renal Physiology;2017-06-01
2. Urinary Smad1 as a New Biomarker for Diabetic Nephropathy in Patients with Type 1 Diabetes Mellitus;Journal of Diabetes & Metabolism;2017
3. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: Inhibition of Smad1 and collagen type IV synthesis;Chemico-Biological Interactions;2015-03
4. New Insights Into Molecular Mechanisms of Diabetic Kidney Disease;American Journal of Kidney Diseases;2014-02
5. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system;Molecular BioSystems;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3